Immudex (original) (raw)
Immudex è una società danese di reagenti e diagnostica fondata nel 2009. L'azienda opera da uffici situati a Copenhagen, in Danimarca, e a Fairfax, in Virginia. Immudex è specializzata nella produzione di Destrameri MHC. I destrameri MHC sono reagenti chimici progettati per rilevare le cellule T specifiche dell'antigene.
| Property | Value |
|---|---|
| dbo:abstract | Immudex is a Danish Reagents and Diagnostics company established in 2009. The company is operating from offices located in Copenhagen, Denmark, and in Fairfax, Virginia. Immudex specializes in the production of MHC Dextramers. MHC Dextramers are chemical reagents that are designed to detect antigen-specific T cells. All Immudex products, whether on the marked or in development, are based on its proprietary MHC Dextramer technology. The use of MHC Dextramers offers a new method to accurately detect and quantify antigen-specific CD8+ T cells. While some of the technology is currently only sold for Research use only (RUO), clinical applications are being actively pursued. Currently, Immudex has several development projects for clinically applicable MHC Dextramers. Even so, the first MHC Dextramers clinical reagent has been developed and approved for clinical in vitro diagnostics in Europe. Namely the CE-marked kit for enumeration of cytomegalovirus-specific T cells. Immudex primarily focuses on the identification of producing large quantities of CD8+ T cells by the means of MHC class I molecules. Even so, the research and development into the application of MHC class II Dextramers might expand the technology. (en) Immudex è una società danese di reagenti e diagnostica fondata nel 2009. L'azienda opera da uffici situati a Copenhagen, in Danimarca, e a Fairfax, in Virginia. Immudex è specializzata nella produzione di Destrameri MHC. I destrameri MHC sono reagenti chimici progettati per rilevare le cellule T specifiche dell'antigene. (it) |
| dbo:foundingYear | 2009-01-01 (xsd:gYear) |
| dbo:keyPerson | dbr:Chief_executive_officer dbr:Chief_operating_officer |
| dbo:product | dbr:MHC_multimer |
| dbo:regionServed | dbr:Fairfax,_Virginia dbr:Copenhagen,_Denmark |
| dbo:type | dbr:Privately_held_company |
| dbo:wikiPageExternalLink | http://www.immudex.com/ |
| dbo:wikiPageID | 35745756 (xsd:integer) |
| dbo:wikiPageLength | 12847 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1105282942 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:Cancer dbr:Privately_held_company dbr:MHC_class_I dbr:MHC_multimer dbr:Borrelia dbr:Denmark dbr:Antigen dbr:Cytomegalovirus dbr:Virginia dbc:Technology_companies_established_in_2009 dbr:Copenhagen dbr:Melanoma dbr:Chief_executive_officer dbr:Chief_operating_officer dbr:Lyme_disease dbr:Major_histocompatibility_complex dbc:Danish_companies_established_in_2009 dbr:Thymus dbr:Tuberculosis dbr:HIV dbr:Alleles dbr:Ernst_&_Young dbr:Europe dbr:Fairfax,_Virginia dbr:Academia dbr:Central_tolerance dbr:Flow_cytometry dbr:Epstein-barr_virus dbr:MHC_class_II dbr:Research_chemical dbr:ELISpot_Assay dbc:Biotechnology_companies_of_Denmark dbc:Life_science_companies_based_in_Copenhagen dbc:Research_support_companies dbc:Companies_based_in_Lyngby-Taarbæk_Municipality dbr:T_cells dbr:Dextran dbr:Diabetes dbr:BK_virus dbr:Human_leukocyte_antigen dbr:Influenza dbr:Natural_killer_cells dbr:Autoimmune_diseases dbr:T_cell dbr:Copenhagen,_Denmark dbr:Borreliosis dbr:CD8+_T_cells |
| dbp:areaServed | dbr:Fairfax,_Virginia dbr:Copenhagen,_Denmark |
| dbp:founded | 2009 (xsd:integer) |
| dbp:homepage | http://www.immudex.com/ |
| dbp:industry | Reagents and Diagnostics (en) |
| dbp:keyPeople | Helene Kähler Hjenner (en) Liselotte Brix (en) |
| dbp:locationCity | dbr:Copenhagen |
| dbp:locationCountry | dbr:Denmark |
| dbp:name | Immudex (en) |
| dbp:predecessor | Dako (en) |
| dbp:products | MHC Dextramer (en) |
| dbp:type | dbr:Privately_held_company |
| dbp:wikiPageUsesTemplate | dbt:Infobox_company |
| dcterms:subject | dbc:Technology_companies_established_in_2009 dbc:Danish_companies_established_in_2009 dbc:Biotechnology_companies_of_Denmark dbc:Life_science_companies_based_in_Copenhagen dbc:Research_support_companies dbc:Companies_based_in_Lyngby-Taarbæk_Municipality |
| gold:hypernym | dbr:Reagents |
| rdf:type | owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatBiotechnologyCompaniesOfDenmark yago:WikicatCompaniesBasedInCopenhagen yago:Abstraction100002137 yago:Company108058098 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920 |
| rdfs:comment | Immudex è una società danese di reagenti e diagnostica fondata nel 2009. L'azienda opera da uffici situati a Copenhagen, in Danimarca, e a Fairfax, in Virginia. Immudex è specializzata nella produzione di Destrameri MHC. I destrameri MHC sono reagenti chimici progettati per rilevare le cellule T specifiche dell'antigene. (it) Immudex is a Danish Reagents and Diagnostics company established in 2009. The company is operating from offices located in Copenhagen, Denmark, and in Fairfax, Virginia. Immudex specializes in the production of MHC Dextramers. MHC Dextramers are chemical reagents that are designed to detect antigen-specific T cells. All Immudex products, whether on the marked or in development, are based on its proprietary MHC Dextramer technology. The use of MHC Dextramers offers a new method to accurately detect and quantify antigen-specific CD8+ T cells. (en) |
| rdfs:label | Immudex (en) Immudex (it) |
| owl:sameAs | freebase:Immudex yago-res:Immudex wikidata:Immudex dbpedia-it:Immudex https://global.dbpedia.org/id/4nWtn |
| prov:wasDerivedFrom | wikipedia-en:Immudex?oldid=1105282942&ns=0 |
| foaf:homepage | http://www.immudex.com/ |
| foaf:isPrimaryTopicOf | wikipedia-en:Immudex |
| foaf:name | Immudex (en) |
| is dbo:wikiPageWikiLink of | dbr:MHC_multimer |
| is foaf:primaryTopic of | wikipedia-en:Immudex |